| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.71B | 62.05B | 63.35B | 64.55B | 58.42B | 55.14B |
| Gross Profit | 13.81B | 13.73B | 13.53B | 15.51B | 14.12B | 14.63B |
| EBITDA | 6.46B | 5.91B | 6.74B | 8.63B | 7.54B | 8.51B |
| Net Income | 1.20B | -20.00M | 1.79B | 4.01B | 3.38B | 4.22B |
Balance Sheet | ||||||
| Total Assets | 94.62B | 101.42B | 105.83B | 121.99B | 116.02B | 109.67B |
| Cash, Cash Equivalents and Short-Term Investments | 25.22B | 26.34B | 35.68B | 37.27B | 38.84B | 38.04B |
| Total Debt | 18.85B | 24.57B | 614.00M | 291.00M | 277.00M | 404.00M |
| Total Liabilities | 29.14B | 35.27B | 14.04B | 14.04B | 11.77B | 11.34B |
| Stockholders Equity | 64.22B | 64.86B | 90.45B | 106.30B | 102.67B | 96.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.56B | 3.57B | 1.02B | 1.82B | 3.89B |
| Operating Cash Flow | 0.00 | 3.00B | 8.12B | 8.37B | 6.07B | 6.44B |
| Investing Cash Flow | 0.00 | -7.56B | 3.34B | -8.57B | -5.00B | -3.86B |
| Financing Cash Flow | 0.00 | -3.14B | -6.47B | -4.70B | -2.44B | -4.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥113.31B | 10.81 | ― | 3.01% | 12.35% | 11.03% | |
74 Outperform | ¥526.52B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
70 Outperform | ¥379.89B | 12.15 | ― | 1.60% | -0.11% | -21.86% | |
69 Neutral | ¥111.82B | 12.01 | ― | 5.78% | 1.24% | 186.45% | |
62 Neutral | ¥107.87B | 23.21 | ― | 3.30% | -1.91% | 7.67% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
48 Neutral | ¥38.80B | -2,015.54 | ― | 5.35% | -2.06% | -100.49% |